Seoul National University Hospital
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 501
- Market Cap
- -
- Website
- https://www.snubh.org
Effects of Probiotics Supplementation on Intestinal Microbiome in Malignancy Pts(Get Pelvic/Abdominal Rtx)
Not Applicable
- Conditions
- Cancer
- Interventions
- Dietary Supplement: probiotics (six probiotic cultures)Dietary Supplement: Placebo
- First Posted Date
- 2012-10-15
- Last Posted Date
- 2013-04-19
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 26
- Registration Number
- NCT01706393
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Role of Perfusion CT in Pancreatic Cancer
- Conditions
- Adenocarcinoma, PancreasNeuroendocrine Carcinoma of Pancreas
- Interventions
- Drug: iopromideProcedure: CT
- First Posted Date
- 2012-10-10
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT01703650
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Switching From Consta® to Sustenna® in Patients With Schizophrenia
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2012-10-02
- Last Posted Date
- 2015-12-08
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT01698216
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
Phase 4
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2012-10-01
- Last Posted Date
- 2019-04-09
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 46
- Registration Number
- NCT01696617
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Web-based International Multi-Center Clinical Study for Parkinson's Disease
Not Applicable
- Conditions
- Parkinson Disease
- Interventions
- Procedure: electrode position
- First Posted Date
- 2012-10-01
- Last Posted Date
- 2015-11-30
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 136
- Registration Number
- NCT01696812
- Locations
- 🇰🇷
Department of Neurosurgery, Seoul National University Hospital, Seoul, Korea, Republic of
A Randomized Trial of Udenafil Therapy in Patients With Mild Pulmonary Hypertension [ULTIMATE-Mild PHT]
- First Posted Date
- 2012-09-28
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT01696240
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
Phase 3
Terminated
- Conditions
- Chronic Hepatitis BRheumatoid ArthritisAnkylosing SpondylitisPsoriatic ArthritisJuvenile Idiopathic Arthritis
- Interventions
- Drug: PlaceboDrug: Entecavir
- First Posted Date
- 2012-09-27
- Last Posted Date
- 2017-03-06
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 43
- Registration Number
- NCT01694264
- Locations
- 🇰🇷
Gachon University Gil Medical Center, Incheon, Korea, Republic of
🇰🇷Inha University Hospital, Incheon, Korea, Republic of
🇰🇷Chonnam National University Hospital, Gwangju, Korea, Republic of
Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid
Not Applicable
Completed
- Conditions
- Orbital Fat Prolapse
- Interventions
- Device: UltheraTM 100 shots
- First Posted Date
- 2012-09-26
- Last Posted Date
- 2014-04-07
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 7
- Registration Number
- NCT01693055
- Locations
- 🇰🇷
Seoul National Univ. Bundang Hospital, Gumi-dong, Bundang-gu, Seongnam-si,, Gyeonggi-do, Korea, Republic of
Clinical Trial to Evaluate the Safety and Efficacy of Scarclinic™ Thin in Surgical Scars
Not Applicable
Completed
- Conditions
- Hypertrophic Surgical Scar
- Interventions
- Device: Scarclinic™ ThinDevice: Scarclinic™ Normal
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT01689857
- Locations
- 🇰🇷
Seoul National Univ. Bundang Hospital, Bundang-gu, Seongnam-si,Gyeonggi-do, Korea, Republic of
Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck Cancer
Phase 2
Completed
- Conditions
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2020-12-08
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 53
- Registration Number
- NCT01689194
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath